Multi-institutional, randomized, double-blind, placebo-controlled trial to assess the efficacy of a mucoadhesive hydrogel (MuGard) in mitigating oral mucositis symptoms in patients being treated with chemoradiation therapy for cancers of the head and neck. [electronic resource]
Producer: 20140620Description: 1433-40 p. digitalISSN:- 1097-0142
- Adult
- Aged
- Aged, 80 and over
- Carcinoma, Squamous Cell -- drug therapy
- Chemoradiotherapy -- adverse effects
- Double-Blind Method
- Female
- Head and Neck Neoplasms -- drug therapy
- Humans
- Hydrogel, Polyethylene Glycol Dimethacrylate -- administration & dosage
- Male
- Middle Aged
- Mouth Mucosa -- drug effects
- Neoplasm Staging
- Placebos
- Squamous Cell Carcinoma of Head and Neck
- Stomatitis -- drug therapy
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.